Back to trial

Eligibility Pre-Screening

Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRC

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 70%

1.Have you been diagnosed with colorectal cancer (CRC) that is non-MSI-H/pMMR (also called microsatellite stable)?